Form 4: GeneDx Holdings CFO Sells Shares
Insider Transaction (Form 4)
Kevin Feeley, CHIEF FINANCIAL OFFICER of GeneDx Holdings Corp., sold 1,285 shares of common stock on September 9, 2026 for $84.22 per share.
Summary
- Option exercise/conversion: acquired 2,462 Class A Common Stock on September 9, 2026; holds 42,761 after (Direct).
- Open-market sale: disposed of 1,285 Class A Common Stock at $84.22 ($108,220) on September 9, 2026; holds 41,476 after (Direct).
- Option exercise/conversion: disposed of 2,462 Restricted Stock Unit on September 9, 2026; holds 2,463 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $108,220 of stock on the open market.
Insider Transactions
Kevin Feeley — Officer (CHIEF FINANCIAL OFFICER)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-09 | Option exercise/conversion | Class A Common Stock | 2,462 | — | — | 42,761 |
| 2026-09-09 | Open-market sale | Class A Common Stock | 1,285 | $84 | $108.2K | 41,476 |
| 2026-09-09 | Option exercise/conversion | Restricted Stock Unit | 2,462 | — | — | 2,463 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-09 | Option exercise/conversion (2,462 shares) |
| 2026-09-09 | Open-market sale (1,285 shares) |
| 2026-09-09 | Option exercise/conversion (2,462 shares) |
Keywords
insider transaction, Form 4, WGS, GeneDx Holdings Corp., bearish, Kevin Feeley
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.